摘要:
A system includes a plurality of computers interconnected by a network including one or more switching nodes. The computers transfer messages over virtual circuits established thereamong. A computer, as a source computer for one or more virtual circuit(s), schedules transmission of messages on a round-robin basis as among the virtual circuits for which it is source computer. Each switching node which forms part of a path for respective virtual circuits also forwards messages for virtual circuits in a round-robin manner, and, a computer, as a destination computer for one or more virtual circuit(s), schedules processing of received messages in a round-robin manner. Round-robin transmission, forwarding and processing at the destination provides a degree of fairness in message transmission as among the virtual circuits established over the network. In addition, messages are transmitted in one or more cells, with the round-robin transmission being on a cell basis, so as to reduce delays which may occur for short messages if a long messages were transmitted in full for one virtual circuit before beginning transmission of a short message for another virtual circuit. For each virtual circuit, the destination computer and each switching node along the path for the virtual circuit can generate a virtual circuit flow control message for transmission to the source computer to temporarily limit transmission over the virtual circuit if the amount of resources being taken up by messages for the virtual circuit exceeds predetermined thresholds, further providing fairness as among the virtual circuits. In addition, each switching node or computer can generate link flow control messages for transmission to neighboring devices in the network to temporarily limit transmission thereto if the amount of resources taken up by all virtual circuits exceeds predetermined thresholds, so as to reduce the likelihood of message loss.
摘要:
The present invention is concerned with an oral pharmaceutical formulation containing a proton pump inhibitor (PPI) which is suitable for the treatment of gastric acid related diseases in man and animals. More specifically, the composition is a paste, and is particularly suitable for delivery of a proton pump inhibitor to horses.
摘要:
A method and apparatus for coaxing a novice operator into dialogue with a touch screen display and for directing the operator to program the machine including a soft display actuator displayed on the first frame of the touch screen display of the user interface, a pointer displayed adjacent to the acutator, the pointer simulating a human action with respect to the actuator, the human action suggesting to the operator the manual engagement of the actuator, and a control responsive to the manual engagement of the actuator to provide a subsequent frame on the touch screen display of the user interface, the subsequent frames providing progressively more complex operator options.
摘要:
Ivermectin, an antiparasitic agent which is insoluble and unstable in water, is formulated in glycerol formal and propylene glycol. These liquid formulations are suitable for parenteral administration for the treatment of parasitic infections and demonstrate improved efficacy and a broadened spectrum over previous formulations.
摘要:
A circuit for regulation of a D.C. output voltage in a switching power supply. The circuit contains a control transformer having primary, secondary and control windings. The output of the circuit is connected from the primary and secondary windings and is controlled by a switching element connected from the control winding. The circuit output error is provided to duty cycle modulation circuitry which varies the duty cycle of the switching element, thereby controlling the output voltage level.
摘要:
A soluble complex of an insoluble drug, exemplified by Rafoxanide is formed with polyvinylpyrrolidone and water. The complex is formed by combining the insoluble drug and polyvinylpyrrolidone in a suitable water miscible organic solvent, preferably acetone or glycerolformal, and water. The complex is formed in situ. The solvent may be removed, if desired, and the complex remains in aqueous solution. The aqueous solution is then suitable for injection and may be used to treat fasciola or liver fluke infections.